Ovarian cancer
- Cytoreductive surgery + platinum chemotherapy are foundations
- Neoadjuvant chemotherapy when upfront surgery is unsuitable
- BRCA/HRD testing guides PARP-maintenance decisions
- Bevacizumab is used in selected first-line/recurrent settings
- Recurrence strategy depends on platinum sensitivity
- Germline genetic testing is important
Use at a glance
- Cytoreductive surgery + platinum chemotherapy are foundations
Choosing treatment
- BRCA/HRD testing guides PARP-maintenance decisions
- Bevacizumab is used in selected first-line/recurrent settings
Treatment selection
- Neoadjuvant chemotherapy when upfront surgery is unsuitable
- Germline genetic testing is important
Patient-specific selection
- Recurrence strategy depends on platinum sensitivity
Self-check
- What is recommended for Ovarian cancer?
Cytoreductive surgery + platinum chemotherapy are foundations.
Drugs used for this (3)
All clinical uses · Open the interactive console ↗
